GV Backs Hair Loss Biotech out of UCLA with PhII set for mid-2024

Pelage Pharmaceuticals, a Los Angeles-based hair loss biotech based on research out of UCLA, has reeled in a $16.75 million Series A and plans to start a mid-stage trial later this year.

See full article below;